These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35759452)

  • 1. Death-Associated Protein Kinase 3 Inhibitors Identified by Virtual Screening for Drug Discovery in Cancer and Hypertension.
    Xue B; Chaddha M; Elasbali AM; Zhu Z; Jairajpuri DS; Alhumaydhi FA; Mohammad T; Abdulmonem WA; Sharaf SE; Hassan MI
    OMICS; 2022 Jul; 26(7):404-413. PubMed ID: 35759452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.
    Anjum F; Mohammad T; Almalki AA; Akhtar O; Abdullaev B; Hassan MI
    OMICS; 2021 Sep; 25(9):580-590. PubMed ID: 34448628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Pim Kinases and DAPK3 to Control Hypertension.
    Carlson DA; Singer MR; Sutherland C; Redondo C; Alexander LT; Hughes PF; Knapp S; Gurley SB; Sparks MA; MacDonald JA; Haystead TAJ
    Cell Chem Biol; 2018 Oct; 25(10):1195-1207.e32. PubMed ID: 30033129
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Alshehri SA; Wahab S; Almoyad MAA
    J Biomol Struct Dyn; 2024 Nov; 42(18):9463-9474. PubMed ID: 37643015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Fragment Design for Drug Discovery and Chemical Biology.
    Rodrigues T; Reker D; Welin M; Caldera M; Brunner C; Gabernet G; Schneider P; Walse B; Schneider G
    Angew Chem Int Ed Engl; 2015 Dec; 54(50):15079-83. PubMed ID: 26486226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Death-associated protein kinase 3 mediates vascular structural remodelling via stimulating smooth muscle cell proliferation and migration.
    Usui T; Sakatsume T; Nijima R; Otani K; Kazama K; Morita T; Kameshima S; Okada M; Yamawaki H
    Clin Sci (Lond); 2014 Oct; 127(8):539-48. PubMed ID: 24814693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
    Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics.
    Yang C; Alam A; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Shamsi A; Bano B; Yadav DK
    Molecules; 2022 May; 27(10):. PubMed ID: 35630545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases.
    Anwar S; Khan S; Shamsi A; Anjum F; Shafie A; Islam A; Ahmad F; Hassan MI
    J Cell Biochem; 2021 Oct; 122(10):1445-1459. PubMed ID: 34121218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical changes of ATP binding pocket may explain loss of kinase activity in mutant DAPK3 in cancer: A molecular dynamic simulation analysis.
    Agarwal T; Annamalai N; Maiti TK; Arsad H
    Gene; 2016 Apr; 580(1):17-25. PubMed ID: 26748242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers.
    Adnan M; Koli S; Mohammad T; Siddiqui AJ; Patel M; Alshammari N; Bardakci F; Elasbali AM; Hassan MI
    OMICS; 2022 Aug; 26(8):461-470. PubMed ID: 35925819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
    Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
    J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 11-Hydroxytephrosin and Torosaflavone A as Potential Inhibitors of 3-Phosphoinositide-Dependent Protein Kinase 1 (PDPK1): Toward Anticancer Drug Discovery.
    Atiya A; Alhumaydhi FA; Sharaf SE; Al Abdulmonem W; Elasbali AM; Al Enazi MM; Shamsi A; Jawaid T; Alghamdi BS; Hashem AM; Ashraf GM; Shahwan M
    Biology (Basel); 2022 Aug; 11(8):. PubMed ID: 36009858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enriching Anticancer Drug Pipeline with Potential Inhibitors of Cyclin-Dependent Kinase-8 Identified from Natural Products.
    Zehra ; Hussain A; AlAjmi MF; Ishrat R; Hassan MI
    OMICS; 2024 Sep; 28(9):478-488. PubMed ID: 39149808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4).
    Mohammad T; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 Apr; 37(7):1813-1829. PubMed ID: 29683402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Network Analyses Implicate Death-Associated Protein Kinase 3 (DAPK3) as a Key Factor in Colitis-Associated Dysplasia Progression.
    Chen HM; MacDonald JA
    Inflamm Bowel Dis; 2022 Oct; 28(10):1485-1496. PubMed ID: 35604388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
    Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.
    Liu W; Khalid M; Wahab S; Faizan Siddiqui M; Hasan Khan S; Sadiq M; Khatoon Z
    J Biomol Struct Dyn; 2024 Jul; 42(10):5219-5228. PubMed ID: 37418235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.